No need to extrapolate.

Worried sarcoma wasn’t one of the multiple primary sites included in the SABR-COMET trial? Here’s a case series of 16 patients with sarcoma treated with SBRT monotherapy for oligomets reporting a remarkable median time to salvage chemo or death of 28 months. | Loi, Radiol Med 2018


Popular Posts